Key result
Fixed-dose perindopril and atorvastatin synergistically lower CV risk through simultaneous treatment of hypertension and dyslipidemia.
A fixed-dose combination of perindopril and atorvastatin offers a synergistic approach to early and simultaneous management of hypertension and dyslipidemia, improving patient adherence and reducing cardiovascular risk.
Supports dual risk-factor management in practice; hypothesis-generating for fixed-dose combinations, requiring RCTs before adoption.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Souček et al. (2020) conducted a review in Hypertension and dyslipidemia. Perindopril and atorvastatin fixed combination was evaluated. A fixed combination of perindopril and atorvastatin provides an effective method for early, simultaneous intervention of hypertension and dyslipidemia to synergistically reduce cardiovascular risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: